---
$id: https://graph.org.ai/products/commodity/51111839
$type: Product
source: UNSPSC
code: "51111839"
title: "Calusterone"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Calusterone

**UNSPSC Code**: 51111839
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a therapeutic androgen and anabolic steroid with the molecular formula C21H32O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0678G6Q58A, chemically known as 17beta-hydroxy-7beta,17-dimethylandrost-4-en-3-one but generally known as calusterone, which bears US NIH Compound Identifier 28204. European Medicines Agency schedules Calusterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06060MIG. The term CALUSTERONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). CALUSTERONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule calusterone under HS 29372900 and SITC 54153. As of Q4 2014, CALUSTERONE remains the US FDA Preferred Term for this commodity. Calusterone bears US NLM identifiers UMLS ID C0006790 and NCI Concept Code C337. SMILES: OC1(C2(C(C3C(C4(C(=CC(=O)CC4)CC3C)C)CC2)CC1)C)C.

